HR Path Strengthens SAP SuccessFactors Expertise as tts digital HR experts Joins the Group
HR Path, a global leader in Human Resources, announces the acquisition of tts digital HR experts GmbH, a specialist in SAP SuccessFactors and SAP HCM consulting, implementation and application management. The addition strengthens HR Path's SAP...
LattePanda Launches the LattePanda Mu Ultra: A Micro x86 Compute Module for On-Device AI
SHANGHAI, Sept. 9, 2026 /PRNewswire/ -- LattePanda Team today launched LattePanda Mu Ultra, a micro x86 compute module purpose-built for on-device AI. Powered by Intel Core Ultra 5 226V and Ultra 7 256V processors, it delivers up to 115 TOPS of AI...
DJI Hosts Filmmakers & Visionaries Session at Venice Production Bridge During the 83rd Venice International Film Festival
New Generation, New Cinematic Language: Osmo Pocket 4P Sparks a New Conversation About Storytelling, Creative Freedom, and Professional Tools. VENICE, Italy, Sept. 9, 2026 /PRNewswire/ -- DJI, the global leader in civilian drones and creative camera...
Cheche Group Announces Proposed Strategic Investment in Global Residential Energy Storage Business, Advancing Green Mobility to Green Energy Strategy
Proposed strategic investment in Long Way Fortune's residential solar-plus-storage business, with potential to increase ownership over time, supporting Cheche's new "Green Mobility + Green Energy" two-pillar strategy BEIJING, Sept. 9, 2026...
Kazia Therapeutics Announces First Patient Dosed in PNOC035 Clinical Study Evaluating Paxalisib for Recurrent Pediatric AT/RT Brain Cancer
Multicenter study to evaluate paxalisib plus gemcitabine for children and young adults with recurrent or progressive AT/RT, where no approved therapies currently exist SYDNEY, Sept. 9, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA)...
Harbour BioMed Partner, Solstice Oncology, announces $225 Million Series A Financing to Advance Porustobart, a Neoadjuvant Immuno-Oncology Therapy
Porustobart, a second-generation Fc-enhanced CTLA-4 antibody, is being advanced across two clinical indications in the neoadjuvant setting, beginning with MSS clinical stage II-III colon cancer Phase 2 trial of porustobart for colon cancer will be...
Reveillon Creations Builds Commercial Infrastructure for Malaysian Talent into China's Creator Economy
Douyin licensing partnership with 3Z LIVE creates a cross-border route into China's short-video market. Talent management and entertainment company pairs production facilities and operational management with commercial representation, giving...
OceanaGold Submits Permit Application and Provides Technical and Exploration Update Supporting Mine Life Extension at Macraes
VANCOUVER, BC, Sept. 9, 2026 /PRNewswire/ -- OceanaGold Corporation (TSX: OGC, NYSE: OGC) ("OceanaGold" or the "Company") announces that it has lodged its application for approval of the Macraes Phase 4 Project ("MP4") under New Zealand's Fast-track...